Literature DB >> 10216187

Hypoxia preconditioning attenuates brain edema associated with kainic acid-induced status epilepticus in rats.

M R Emerson1, S R Nelson, F E Samson, T L Pazdernik.   

Abstract

Kainic acid (KA)-induced seizures elicit edema associated with necrosis in susceptible brain regions (e.g., piriform cortex and hippocampal CA1 and CA3 regions). To test the hypothesis that hypoxia preconditioning protects against KA-induced edema formation, adult male rats were exposed to a 9% O2, 91% N2 atmosphere for 8 h. KA (14 mg/kg, i.p.) was administered 1, 3, 7, or 14 days later. Regional analysis of edema indicated that hypoxia exposure attenuated edema formation in piriform and frontal cortices and hippocampus when KA was given 1, 3, or 7 days later but not 14 days after hypoxia. Cycloheximide (2 mg/kg s.c.) given 1 h prior to hypoxia prevented the protective effect of hypoxia on KA-induced edema attenuation in the piriform cortex and hippocampus. Thus, hypoxic challenge induces a general adaptive response that protects against the seizure-associated pathophysiology, with no direct relationship to seizure intensity. This response may involve stress-related transcription factors and effector proteins. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216187     DOI: 10.1016/s0006-8993(99)01195-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

Review 1.  Hypoxic preconditioning protects against ischemic brain injury.

Authors:  Frank R Sharp; Ruiqiong Ran; Aigang Lu; Yang Tang; Kenneth I Strauss; Todd Glass; Tim Ardizzone; Myriam Bernaudin
Journal:  NeuroRx       Date:  2004-01

2.  The roles of P2X7 receptor in regional-specific microglial responses in the rat brain following status epilepticus.

Authors:  Hea Kyung Choi; Hea Jin Ryu; Ji-Eun Kim; Seung-Mook Jo; Hui-Chul Choi; Hong-Ki Song; Tae-Cheon Kang
Journal:  Neurol Sci       Date:  2011-08-16       Impact factor: 3.307

3.  Silencing of P2X7R by RNA interference in the hippocampus can attenuate morphological and behavioral impact of pilocarpine-induced epilepsy.

Authors:  Rebeca Padrão Amorim; Michelle Gasparetti Leão Araújo; Jorge Valero; Iscia Lopes-Cendes; Vinicius Davila Bitencourt Pascoal; João Oliveira Malva; Maria José da Silva Fernandes
Journal:  Purinergic Signal       Date:  2017-07-13       Impact factor: 3.765

4.  Down-regulated expression of aquaporin-4 in the cerebellum after status epilepticus.

Authors:  Hui Tang; Chuan Shao; Jiaquan He
Journal:  Cogn Neurodyn       Date:  2016-11-14       Impact factor: 5.082

5.  Seizure preconditioning and epileptic tolerance: models and mechanisms.

Authors:  Eva M Jimenez-Mateos; David C Henshall
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2009-11-02

6.  Gene expression changes after seizure preconditioning in the three major hippocampal cell layers.

Authors:  Karin Borges; Renee Shaw; Raymond Dingledine
Journal:  Neurobiol Dis       Date:  2007-01-18       Impact factor: 5.996

7.  P2X7 receptor regulates leukocyte infiltrations in rat frontoparietal cortex following status epilepticus.

Authors:  Ji-Eun Kim; Hea Jin Ryu; Seong-Il Yeo; Tae-Cheon Kang
Journal:  J Neuroinflammation       Date:  2010-10-12       Impact factor: 8.322

8.  Cardiac protection by preconditioning is generated via an iron-signal created by proteasomal degradation of iron proteins.

Authors:  Baruch E Bulvik; Eduard Berenshtein; Esther G Meyron-Holtz; Abraham M Konijn; Mordechai Chevion
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 9.  Current insights into the molecular mechanisms of hypoxic pre- and postconditioning using hypobaric hypoxia.

Authors:  Elena Rybnikova; Mikhail Samoilov
Journal:  Front Neurosci       Date:  2015-10-23       Impact factor: 4.677

Review 10.  Neuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases.

Authors:  Jia Liu; Yakun Gu; Mengyuan Guo; Xunming Ji
Journal:  CNS Neurosci Ther       Date:  2021-08       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.